Novartis is one of the world's top pharmaceutical companies, and along with neighbours Roche, the mainstay of Switzerland's centuries-long contribution to new medicines. Headquartered in Basel ...

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,098.72 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

Basel (City) Feb 03, 2025 TM Academy fellow in Data Science in Preclinical Safety Early Career (Fixed Term), Full time Pharma Research Switzerland Basel (City) Feb 03, 2025 Senior Clinical Coding ...

This initiative underscores the crucial role of youth in shaping the future of architecture through policy, education, and training. Enter the Howard Waterfall Retreat ‪Architecture ...

The Boulder Museum of Contemporary Art has selected SO-IL, in collaboration with Boulder-based company Coburn Architecture, as its design team for the North Boulder Creative Campus project.

Anthos was founded by Blackstone Life Sciences and Novartis in 2019 with the exclusive global rights from Novartis to develop, manufacture, and commercialize abelacimab, a novel factor XI ...